✦ LIBER ✦

Endothelial Cells Elicit Immune-Enhancing Responses to Dengue Virus Infection

✍ Scribed by Dalrymple, N. A.; Mackow, E. R.

Book ID: 115527161
Publisher: American Society for Microbiology
Year: 2012
Tongue: English
Weight: 751 KB
Volume: 86
Category: Article
ISSN: 0022-538X
DOI: 10.1128/jvi.00213-12

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aedes aegypti Saliva Enhances Dengue Vir

Aedes aegypti Saliva Enhances Dengue Virus Infection of Human Keratinocytes by Suppressing Innate Immune Responses

✍ Surasombatpattana, Pornapat; Patramool, Sirilaksana; Luplertlop, Natthanej; Ysse 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 179 KB

Genetic polymorphisms of molecules invol

Genetic polymorphisms of molecules involved in host immune response to dengue virus infection

✍ Xin Fang; Zhen Hu; Weilong Shang; Junmin Zhu; Chuanshan Xu; Xiancai Rao 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 561 KB

Long-term memory cellular immune respons

Long-term memory cellular immune response to dengue virus after a natural primary infection

✍ Beatríz Sierra; Gissel García; Ana B. Pérez; Luis Morier; Rayner Rodríguez; Mayl 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 432 KB

Dengue virus replication in infected hum

Dengue virus replication in infected human keratinocytes leads to activation of antiviral innate immune responses

✍ Pornapat Surasombatpattana; Rodolphe Hamel; Sirilaksana Patramool; Natthanej Lup 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 771 KB

A DNA vaccine candidate encoding the str

A DNA vaccine candidate encoding the structural prM/E proteins elicits a strong immune response and protects mice against dengue-4 virus infection

✍ Danielle Malta Lima; Sérgio Oliveira de Paula; Rafael Freitas de Oliveira França 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 601 KB

Spleen-derived dendritic cells engineere

Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses

✍ Katsuyoshi Furumoto; Shigeki Arii; Seiji Yamasaki; Masaki Mizumoto; Akira Mori; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 461 KB 👁 1 views

The major goal in cancer immunotherapy is the induction of tumor-specific T lymphocytes capable of killing tumor cells. As both dendritic cells (DCs) and interleukin-12 (IL-12) can play immunostimulatory roles in vivo, the use of a combination of these has become a promising approach. In the present